Illumina (NASDAQ: ILMN) and Bionano Genomics (NASDAQ: BNGO) might both make gene sequencing devices, but as investments the two couldn't be more different. Whereas Bionano is a new entrant to the market and still has a lot to prove to its investors as well as the scientific community, Illumina is the top dog that's fighting to maintain its position.

So which is the better choice for investors who want exposure to one of the biopharma sector's most important segments? Let's dive in and take a look at each business.

Image source: Getty Images.

Continue reading

Source Fool.com